Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06316206
Other study ID # EFFIPREP
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date January 1, 2023
Est. completion date March 1, 2024

Study information

Verified date April 2024
Source University of Palermo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The presence of a thin endometrium plays an important role in enabling the best conditions for hysteroscopic surgery. Recently, for this purpose, many studies have evaluated the effect of preoperative administration of a variety of drugs. We explored the efficacy of random started 14-day administration of Ethinylestradiol/Dienogest, in rapid preparation of endometrium for hysteroscopic polypectomy.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date March 1, 2024
Est. primary completion date August 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 45 Years and older
Eligibility Inclusion Criteria: - Patients with endometrial polyps. Exclusion Criteria: - Patients with other endometrial pathologies.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ethinylestradiol/Dienogest 0.03mg/2mg
Endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Ethinylestradiol/Dienogest 0.03mg/2mg at any time of the menstrual cycle

Locations

Country Name City State
Italy Andrea Etrusco Palermo
Italy Marco Monti Roma

Sponsors (2)

Lead Sponsor Collaborator
University of Palermo University of Roma La Sapienza

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of endometrial preparation Quality of endometrial preparation assessed visually intraoperatively by the surgeon using a visual analog scale from 0 to 5. 14th day of treatment
See also
  Status Clinical Trial Phase
Recruiting NCT05001282 - A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRĪ±) Phase 1/Phase 2
Recruiting NCT04145518 - Mechanistic Characterization of Uterine Pain Phase 4
Recruiting NCT03756480 - Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance
Recruiting NCT03748238 - Endometrial Injury In Recurrent Implantation Failure N/A
Completed NCT05283642 - D-chiro-inositol and Endometrial Thickness N/A
Completed NCT03519763 - Intrauterine Microbiota During IVF in Patients Affected With Isthmocele.
Completed NCT03207074 - Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? N/A
Recruiting NCT03289468 - Study of Diagnosis of Color Power Doppler Combined Minimally Invasive Sampling for Endometrial Diseases
Completed NCT03755973 - Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity Phase 4
Withdrawn NCT04184323 - SIRT-1 Antagonism for Endometrial Receptivity Phase 2
Completed NCT06316180 - The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation Phase 4
Completed NCT06316219 - The Use of Nomegestrol Acetate/Estradiol in Random Start Rapid Endometrial Preparation Phase 4
Completed NCT06324851 - The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation Phase 4
Recruiting NCT06264921 - A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors Phase 1
Completed NCT03060603 - Proliferative Effects of Erythropoietin on Human Endometrium N/A
Completed NCT01808898 - Role of Intrauterine Cornual Block in Combination With Direct Cervical Block in Outpatient Endometrial Ablation Phase 4
Completed NCT05472740 - Transcutaneous Electrical Nerve Stimulation During Outpatient Endometrial Biopsy N/A
Completed NCT02716636 - Fast Versus Slow Tenaculum Placement N/A